| Stroud & Stroud | |
|
731 N 2nd St, Suite D, Albemarle, NC 28001-3362 | |
| (704) 983-3183 | |
| (704) 983-3183 |
| Full Name | Stroud & Stroud |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 731 N 2nd St, Albemarle, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497943492 | NPI | - | NPPES |
| 0279P | Other | NC | BC/BS |
| 08279P | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 2413 (North Carolina) | Primary |
| Provider Name | Deidra A Curlee |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1275604746 PECOS PAC ID: 8123003936 Enrollment ID: I20130104000363 |
News Archive
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered that the genetic mechanism which destroys brain cells is responsible for early development of Alzheimer's Disease in people with Down Syndrome and for development of Alzheimer's Disease in general population - providing a potential new target for drugs that could forestall dementia in people with either condition.
In a study conducted at the University of Helsinki, Finland, 136 adults adhered to one of three study diets for 12 weeks. One of them corresponded to the average Finnish diet, containing roughly 70% animal-derived protein of total protein, while most of the plant-based protein originated from cereal products.
Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stroud & Stroud 731 N 2nd St, Suite D, Albemarle, NC 28001-3362 Ph: (704) 983-3183 | Stroud & Stroud 731 N 2nd St, Suite D, Albemarle, NC 28001-3362 Ph: (704) 983-3183 |
News Archive
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
Researchers at the University of British Columbia and Vancouver Coastal Health Research Institute have discovered that the genetic mechanism which destroys brain cells is responsible for early development of Alzheimer's Disease in people with Down Syndrome and for development of Alzheimer's Disease in general population - providing a potential new target for drugs that could forestall dementia in people with either condition.
In a study conducted at the University of Helsinki, Finland, 136 adults adhered to one of three study diets for 12 weeks. One of them corresponded to the average Finnish diet, containing roughly 70% animal-derived protein of total protein, while most of the plant-based protein originated from cereal products.
Enobia Pharma, today announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia, a serious, rare metabolic bone disorder.
› Verified 7 days ago
Derek Tucker, DC, CSCS Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 315 East St, Albemarle, NC 28001 Phone: 704-985-5472 | |
Dr. Connie Eckman, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1738 Badin Rd, Albemarle, NC 28001 Phone: 704-983-2177 Fax: 704-983-2212 | |
Carolina Health Solutions, Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 1738 Badin Rd, Albemarle, NC 28001 Phone: 704-983-2177 Fax: 844-378-4197 | |
Dr. John William Eckman Iii, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 1738 Badin Rd, Albemarle, NC 28001 Phone: 704-983-2177 Fax: 704-983-2212 | |
Dr. Deidra A Curlee, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 731 N 2nd St, Ste. D, Albemarle, NC 28001 Phone: 704-983-3183 Fax: 704-983-8739 | |
Albemarle Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1738 Badin Rd, Albemarle, NC 28001 Phone: 704-983-2177 Fax: 704-983-2212 |